Clinical trial
A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease
NCT04590508 is registered in ClinicalTrials.gov with National University of Natural Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease
- Lead sponsor
- National University of Natural Medicine
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 1, 2020
- Completion date
- July 30, 2025
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.